Article info
PDFResearch letter
Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris
- Correspondence to Dr Valentina Isernia, Infectious diseases, Hopital Bichat - Claude-Bernard, Paris, France; valentina.isernia{at}aphp.fr
Citation
Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris
Publication history
- Received May 27, 2020
- Revised August 13, 2020
- Accepted August 16, 2020
- First published September 2, 2020.
Online issue publication
October 11, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.